Related references
Note: Only part of the references are listed.Bradykinin forming capacity of oversulfated chondroitin sulfate contaminated heparin in vitro
Albert Adam et al.
BIOMATERIALS (2010)
Analysis of crude heparin by 1H NMR, capillary electrophoresis, and strong-anion-exchange-HPLC for contamination by over sulfated chondroitin sulfate
David A. Keire et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2010)
Assay of possible economically motivated additives or native impurities levels in heparin by 1H NMR, SAX-HPLC, and anticoagulation time approaches
David A. Keire et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2010)
Oversulfated chondroitin sulfate is not the sole contaminant in heparin
Jing Pan et al.
NATURE BIOTECHNOLOGY (2010)
Heparin-induced anaphylactic and anaphylactoid reactions: two distinct but overlapping syndromes
Theodore E. Warkentin et al.
EXPERT OPINION ON DRUG SAFETY (2009)
Glycosaminoglycan origin and structure revealed by multivariate analysis of NMR and CD spectra
Timothy R. Rudd et al.
GLYCOBIOLOGY (2009)
Analysis of heparin sodium by SAX/HPLC for contaminants and impurities
Michael L. Trehy et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2009)
Lessons learned from the contamination of heparin
Haiying Liu et al.
NATURAL PRODUCT REPORTS (2009)
Orthogonal analytical approaches to detect potential contaminants in heparin
Marco Guerrini et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Quality assessment of unfractionated heparin using 1H nuclear magnetic resonance spectroscopy
T. Beyer et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2008)
The FDA and safety - beyond the heparin crisis
Cato T. Laurencin et al.
NATURE BIOTECHNOLOGY (2008)
Oversulfated chondroitin sulfate is a contaminant in heparin associated with adverse clinical events
Marco Guerrini et al.
NATURE BIOTECHNOLOGY (2008)
Contaminated heparin associated with adverse clinical events and activation of the contact system
Takashi Kei Kishimoto et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Quantitative determination of disaccharide content in digested unfragmented heparin and low molecular weight heparin by direct-infusion electrospray mass spectrometry
Johanna E. Camara et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2007)
Enzymatic redesigning of biologically active heparan sulfate
JH Chen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Complex glycosaminoglycans: profiling substitution patterns by two-dimensional nuclear magnetic resonance spectroscopy
M Guerrini et al.
ANALYTICAL BIOCHEMISTRY (2005)
Heparin and heparan sulfate: structure and function
DL Rabenstein
NATURAL PRODUCT REPORTS (2002)
Conformation and dynamics of heparin and heparan sulfate
B Mulloy et al.
GLYCOBIOLOGY (2000)
Share Paper
